Prefilled insulin device with reduced injection force: patient perception and accuracy

References

• Bashoff EC, Beaser RS. Insulin therapy and the reluctant patient. Overcoming obstacles to success. Postgrad Med 1995; 97:86-90, 3-61Bashoff EC, Beaser RS. Insulin therapy and the reluctant patient. Overcoming obstacles to success. Postgrad Med 1995; 97:86-90, 3-6
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):S89–1002Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):S89–100
   PubMedGoogle Scholar
• Puxty JA, Hunter DH, Burr WA. Accuracy of insulin injection in elderly patients. Br Med J (Clin Res Ed) 1983;287:17623Puxty JA, Hunter DH, Burr WA. Accuracy of insulin injection in elderly patients. Br Med J (Clin Res Ed) 1983;287:1762
   PubMed Web of Science ®Google Scholar
• Kesson CM, Bailie GR. Do diabetic patients inject accurate doses of insulin? Diabetes Care. 1981;4:3334Kesson CM, Bailie GR. Do diabetic patients inject accurate doses of insulin? Diabetes Care. 1981;4:333
   PubMed Web of Science ®Google Scholar
• Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999; 106:57-8, 61-4, 85Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999; 106:57-8, 61-4, 8
   Google Scholar
• Chantelau E, Schiffers T, Schutze J. et al. Effect of patient-selected intensive insulin therapy on quality of life. Patient Educ Couns 1997;30:167–736Chantelau E, Schiffers T, Schutze J. et al. Effect of patient-selected intensive insulin therapy on quality of life. Patient Educ Couns 1997;30:167–73
   PubMed Web of Science ®Google Scholar
• Kadiri A, Chraibi A, Marouan F. et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15–237Kadiri A, Chraibi A, Marouan F. et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15–23
   PubMed Web of Science ®Google Scholar
• Albano S. Assessment of quality of treatment in insulin-treated patients with diabetes using a pre-filled insulin pen. The ORBITER Study Group. Acta Biomed 2004;75:34–98Albano S. Assessment of quality of treatment in insulin-treated patients with diabetes using a pre-filled insulin pen. The ORBITER Study Group. Acta Biomed 2004;75:34–9
   PubMedGoogle Scholar
• Lombardo F, Salzano G, Messina MF. et al. Compliance and administration methods in management of type 1 diabetes. Acta Biomed 2005;76(Suppl 3):66–99Lombardo F, Salzano G, Messina MF. et al. Compliance and administration methods in management of type 1 diabetes. Acta Biomed 2005;76(Suppl 3):66–9
   PubMedGoogle Scholar
• Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498–50510Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498–505
   PubMed Web of Science ®Google Scholar
• Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69–7411Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69–74
   PubMed Web of Science ®Google Scholar
• Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999; 22:137–4012Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999; 22:137–40
   PubMed Web of Science ®Google Scholar
• Coscelli C, Lostia S, Lunetta M. et al. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173–713Coscelli C, Lostia S, Lunetta M. et al. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173–7
   PubMed Web of Science ®Google Scholar
• IMS Health. Estimated number of patients using FlexPen®, based on worldwide sales in number of packs sold, IMS world wide data Q4’07 and Daily Defined Dosage (DDD) for insulin as issued by WHO 2007.14IMS Health. Estimated number of patients using FlexPen®, based on worldwide sales in number of packs sold, IMS world wide data Q4’07 and Daily Defined Dosage (DDD) for insulin as issued by WHO 2007.
   Google Scholar
• Asakura T, Seino H. Insulin dosing accuracy with FlexPen® versus syringe by healthcare professionals and healthy volunteers. Diabetes 2005;54 (Suppl 1):A498–915Asakura T, Seino H. Insulin dosing accuracy with FlexPen® versus syringe by healthcare professionals and healthy volunteers. Diabetes 2005;54 (Suppl 1):A498–9
   Google Scholar
• Asakura T. Comparison of the dosing accuracy of two insulin injection devices. J Clin Res 2005;8:33–4016Asakura T. Comparison of the dosing accuracy of two insulin injection devices. J Clin Res 2005;8:33–40
   Google Scholar
• Pfutzner A, Weise A, Sun H, et al. Differences in dose accuracy of insulin pens. in 43rd EASD Annual Meeting, 2007. Amsterdam, The Netherlands.17Pfutzner A, Weise A, Sun H, et al. Differences in dose accuracy of insulin pens. in 43rd EASD Annual Meeting, 2007. Amsterdam, The Netherlands.
   Google Scholar
• Asakura T, Seino H, Kageyama M. et al. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opinion 2008;24:1429–3418Asakura T, Seino H, Kageyama M. et al. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opinion 2008;24:1429–34
   PubMed Web of Science ®Google Scholar
• Pen-injectors for medical use – Part 1: Pen-injectors – requirements and test methods. ISO 11608-1:2000-2001.19Pen-injectors for medical use – Part 1: Pen-injectors – requirements and test methods. ISO 11608-1:2000-2001.
   Google Scholar
• Ziegler D, Gries FA, Spuler M. et al. The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med 1993;(10 Suppl 2):82–6S20Ziegler D, Gries FA, Spuler M. et al. The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med 1993;(10 Suppl 2):82–6S
   Google Scholar
• Schady W, Abuaisha B, Boulton AJ. Observations on severe ulnar neuropathy in diabetes. J Diabetes Complicat 1998; 12:128–3221Schady W, Abuaisha B, Boulton AJ. Observations on severe ulnar neuropathy in diabetes. J Diabetes Complicat 1998; 12:128–32
   PubMed Web of Science ®Google Scholar
• Savas S, Koroglu BK, Koyuncuoglu HR. et al. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:77–8322Savas S, Koroglu BK, Koyuncuoglu HR. et al. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:77–83
   PubMed Web of Science ®Google Scholar
• Costa SD, Brackenridge B, Hicks D. A comparison of insulin pen use in the United States and the United Kingdom. Diabet Educ 2002;1:52–623Costa SD, Brackenridge B, Hicks D. A comparison of insulin pen use in the United States and the United Kingdom. Diabet Educ 2002;1:52–6
   Google Scholar
• Thurman JE. Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States. Endocr Pract 2007;13:672–824Thurman JE. Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States. Endocr Pract 2007;13:672–8
   PubMedGoogle Scholar
• Bohannon NJ, Ohannesian JP, Burdan AL. et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049–6725Bohannon NJ, Ohannesian JP, Burdan AL. et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049–67
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495–726Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495–7
   PubMed Web of Science ®Google Scholar
• Stockl K, Ory C, Vanderplas A. et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007; 23:133–4627Stockl K, Ory C, Vanderplas A. et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007; 23:133–46
   PubMed Web of Science ®Google Scholar